These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25986885)

  • 1. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.
    Martínez-Pinilla E; Rodríguez-Pérez AI; Navarro G; Aguinaga D; Moreno E; Lanciego JL; Labandeira-García JL; Franco R
    Biochem Pharmacol; 2015 Jul; 96(2):131-42. PubMed ID: 25986885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin AT
    Rivas-Santisteban R; Rodriguez-Perez AI; Muñoz A; Reyes-Resina I; Labandeira-García JL; Navarro G; Franco R
    J Neuroinflammation; 2020 Aug; 17(1):243. PubMed ID: 32807174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
    Martínez-Pinilla E; Reyes-Resina I; Oñatibia-Astibia A; Zamarbide M; Ricobaraza A; Navarro G; Moreno E; Dopeso-Reyes IG; Sierra S; Rico AJ; Roda E; Lanciego JL; Franco R
    Exp Neurol; 2014 Nov; 261():44-52. PubMed ID: 24967683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
    Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine modulates allosteric D
    Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
    Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia.
    Rivas-Santisteban R; Lillo J; Muñoz A; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G; Franco R
    Neurotherapeutics; 2021 Apr; 18(2):998-1016. PubMed ID: 33474655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.
    Huang L; Wu DD; Zhang L; Feng LY
    Acta Pharmacol Sin; 2013 Oct; 34(10):1292-300. PubMed ID: 23933651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation.
    Rico AJ; Dopeso-Reyes IG; Martínez-Pinilla E; Sucunza D; Pignataro D; Roda E; Marín-Ramos D; Labandeira-García JL; George SR; Franco R; Lanciego JL
    Brain Struct Funct; 2017 May; 222(4):1767-1784. PubMed ID: 27612857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity.
    Domazet I; Holleran BJ; Richard A; Vandenberghe C; Lavigne P; Escher E; Leduc R; Guillemette G
    Mol Pharmacol; 2015 Jun; 87(6):982-95. PubMed ID: 25808928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence.
    Pelassa S; Guidolin D; Venturini A; Averna M; Frumento G; Campanini L; Bernardi R; Cortelli P; Buonaura GC; Maura G; Agnati LF; Cervetto C; Marcoli M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral control by striatal adenosine A
    Taura J; Valle-León M; Sahlholm K; Watanabe M; Van Craenenbroeck K; Fernández-Dueñas V; Ferré S; Ciruela F
    Genes Brain Behav; 2018 Apr; 17(4):e12432. PubMed ID: 29053217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
    Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
    Klewe IV; Nielsen SM; Tarpø L; Urizar E; Dipace C; Javitch JA; Gether U; Egebjerg J; Christensen KV
    Neuropharmacology; 2008 Jun; 54(8):1215-22. PubMed ID: 18455202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
    Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
    Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the fate of type I angiotensin receptor after biased activation.
    Szakadáti G; Tóth AD; Oláh I; Erdélyi LS; Balla T; Várnai P; Hunyady L; Balla A
    Mol Pharmacol; 2015 Jun; 87(6):972-81. PubMed ID: 25804845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.